GlassScriptPhysician profile
Richard I Silver
NPI 1346573912
$5,566.58
in general payments reported to CMS, 2019-2025
24 companies · $312 in 2025
The $312 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,841 · 2020: $60.74 · 2021: $39.17 · 2022: $39.58 · 2023: $111 · 2024: $163 · 2025: $312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $586.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $586.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,110.23 | 2019-2025 | |
| Coloplast Corp | $307.45 | 2019-2025 | |
| Astellas Pharma US INC | $215.33 | 2019-2021 | |
| Procept Biorobotics Corporation | $165.94 | 2025 | |
| Boston Scientific Corporation | $101.92 | 2021-2023 | Spaceoar Vue System - 10ml |
| Bayer Healthcare Pharmaceuticals INC. | $85.55 | 2019 | |
| Dendreon Pharmaceuticals LLC | $79.55 | 2019 | |
| Antares Pharma, INC. | $59.00 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $58.91 | 2019 | |
| Janssen Biotech, INC. | $55.39 | 2019 | |
| Pfizer INC. | $50.99 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $44.79 | 2020 | |
| Blue Earth Diagnostics | $37.28 | 2019 | |
| Allergan, INC. | $33.24 | 2019 | |
| Axonics, INC. | $25.06 | 2023 | Axonics |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $23.01 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $17.47 | 2024 | Exparel |
| Urovant Sciences INC | $16.57 | 2022 | |
| Mission Pharmacal Company | $16.35 | 2019 | |
| 180 Medical, INC. | $16.19 | 2019 | |
| Avadel Specialty Pharmaceuticals, LLC | $13.27 | 2019 | |
| Metuchen Pharmaceuticals | $12.48 | 2019 | |
| Amgen INC. | $10.84 | 2019 | |
| Travere Therapeutics, INC. | $9.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Silver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.